Loading song details...
A Phase Ib Study Of PRT503 PRMT5 Inhibitor In R Splicing Factor Mutated Myeloid Malignancies
No description available.
MP3 Download
Video Download
Related Songs
3:15
Overview Of A Phase Ib Study Venetoclax And Obinutuzumab In CLL
5:50
A Phase Ib Single Arm Study Of Bintrafusp Alfa
1:53
Long Term Results Of A Phase Ib Trial Isa VRd In Newly Diagnosed Transplant Ineligible Myeloma
3:28
A Phase Ib Trial Of Fixed Volume Isatuximab Infusion In Newly Diagnosed Multiple Myeloma
2:58
Results Of A Phase Ib Study Ibrutinib Obinutuzumab In R CLL
1:44
Dr Plimack On A Phase Ib Study Of Pembrolizumab In Bladder Cancer
1:18
Preliminary Results Of A Phase Ib Study Combining ABT 199 And Obinutuzumab In CLL
1:52
A Phase Ib Trial Investigating The Combination Of Ruxolitinib And Duvelisib In R T Cell Lymphoma
3:16
A Phase Ib Study Of PRT503 PRMT5 Inhibitor In R Splicing Factor Mutated Myeloid Malignancies
3:08
Adam Craig Just A Phase Official Video
1:24
Dr Posadas On A Phase Ib Study Of Abiraterone Plus Docetaxel For MCRPC
2:41
A Phase Ib Study Of Venetoclax Plus Pola R CHP In The Frontline For Patients With DLBCL
34:21
Phase I Clinical Trials Objectives Design And Endpoints
3:02
Update On Phase Ib Trial Of AVID200 In Myelofibrosis
3:03
A Phase Ib Study Of Venetoclax Plus 7 3 Induction Chemotherapy In Newly Diagnosed AML
2:43
The Results Of A Phase Ib II Study CPX 351 Plus Venetoclax In Patients With R AML
3:34
Three Year Follow Up Of A Phase Ib Trial Mosunetuzumab Plus Polatuzumab Vedotin In R DLBCL
3:11
A Phase Ib Study Of Add On Therapy With CK0804 In Myelofibrosis Suboptimal Ruxolitinib Response
1:59
Dr Lindeman On Rationale For A Phase Ib Trial Of Venetoclax And Tamoxifen In Breast Cancer
3:39